Early Detection Research Network

APOE

Aliases:
This biomarker is also known as:
  • APOE,
  • ApoE4,
  • AD2,
  • Alzheimer Disease 2 (APOE*E4-Associated, Late Onset),
  • LPG,
  • APO-E,
  • Apo-E,
  • Apolipoprotein E,
  • LDLCQ5,
  • Apolipoprotein E3,

Description…

From NCBI Gene: The protein encoded by this gene is a major apoprotein of the chylomicron. It binds to a specific liver and peripheral cell receptor, and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. This gene maps to chromosome 19 in a cluster with the related apolipoprotein C1 and C2 genes. Mutations in this gene result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants. [provided by RefSeq, Jun 2016]

Datasets

There are no datasets associated with this biomarker.

Attributes
QA State: Under Review
Type: Genomic
HGNC Name:

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact the Informatics Center if you should have access to this biomarker.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact the Informatics Center if you should have access to this biomarker.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact the Informatics Center if you should have access to this biomarker.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact the Informatics Center if you should have access to this biomarker.

Version 5.0.2